mTOR: An attractive therapeutic target for osteosarcoma?

Osteosarcoma (OS) is a common primary malignant bone tumor with high morbidity and mortality in children and young adults. How to improve poor prognosis of OS due to resistance to chemotherapy remains a challenge. Recently, growing findings show activation of mammalian target of rapamycin (mTOR), is...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Liu, Congwei, Liu, Bei, Qing, Tao, Yang, Ruiguo, Wang, Heze, Yu, Bo, Dou, Zhihong, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226621/
https://www.ncbi.nlm.nih.gov/pubmed/27177330
http://dx.doi.org/10.18632/oncotarget.9305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226621/
https://www.ncbi.nlm.nih.gov/pubmed/27177330
http://dx.doi.org/10.18632/oncotarget.9305

Ejemplares similares